NCT05838963 is a clinical trial of CTQ-SSS scores in Carpal Tunnel Syndrome, sponsored by Ahram Canadian University.

Who is sponsoring NCT05838963?

NCT05838963 is sponsored by Ahram Canadian University.

What drugs are being tested in NCT05838963?

Interventions in NCT05838963: CTQ-SSS scores.

What condition does NCT05838963 study?

NCT05838963 studies Carpal Tunnel Syndrome.

Is NCT05838963 still recruiting?

NCT05838963 is currently status unknown. Last updated 6 July 2023.

Last reviewed 2023-07-06 · How we verify

NCT05838963

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predictive Value of Baseline CTQ-SSS Scores for Progression to Carpal Tunnel Release Surgery: A Cohort Study

Status unknown Last updated 6 July 2023

What this trial tests

trial testing CTQ-SSS scores in Carpal Tunnel Syndrome in 200 participants. Status unknown.

Timeline

12 July 2023

Primary endpoint
1 November 2024

1 November 2024

Quick facts

Lead sponsor	Ahram Canadian University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	12 July 2023
Primary completion	1 November 2024
Estimated completion	1 November 2024
Sites	1 location across Egypt

Drugs / interventions tested

CTQ-SSS scores

Conditions studied

Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Ahram Canadian University

Who can join

Adults 18 to 60, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine the predictive value of baseline CTQ-SSS scores for progression to carpal tunnel release (CTR) surgery in patients with carpal tunnel syndrome (CTS). It will be a prospective cohort study involving at least 200 patients with CTS who are undergoing nonsurgical management. Participants will complete the CTQ-SSS and other functional measures at baseline, 3 months, 6 months, and 12 months, and the primary outcome will be progression to CTR surgery. Logistic regression models will be used to assess the predictive value of baseline CTQ-SSS scores for progression to CTR surgery, adjusting for potential confounding factors such as age, sex, and baseline symptom severity. The results of this study can help clinicians identify patients who may benefit from early surgical intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting

Other Ahram Canadian University trials

Trials by the same sponsor.

NCT07305610 — INFLUENCE OF SELECTED POSITIONS ON HIP ABDUCTORS STRENGTH AND ACTIVATION IN PATELLOFEMORAL PAIN SYNDROME IN MALES · not yet recruiting
NCT07102992 — Post Burn Cubital Tunnel Syndrome Response to High Intensity Laser Therapy Versus Shock Wave Therapy · NA · completed
NCT07103109 — Impact of Proximal Motor Control Exercise on Scapular Muscles Activation Pattern Post Mastectomy · NA · recruiting
NCT06978426 — Hand-Held Dynamometer Assessment: E-Sports Grip-Asymmetry Index as a Predictor of Wrist Pain · recruiting
NCT06508190 — Free Walking Exercise in Obstructive Sleep Apnea Patients With Non-alcoholic Fatty Liver · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05838963 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahram Canadian University
Last refreshed: 6 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05838963.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing